Connect your AI

GeneDx Holdings WGS Total Liabilities

Total Liabilities at other companies

Natera, Inc.NTRA

$125.55M-74.5%

Tempus AI, Inc.TEM

$1.72B+41.2%

Bio-Rad LaboratoriesBIO

$2.94B+3.2%

RevvityRVTY

$4.81B+1.9%

Labcorp HoldingsLH

$10.34B+11.4%

IlluminaILMN

——

Other financials

Income statement

Revenue$102.3M+17.4%

Gross profit$68.2M+16.6%

Operating income-$57.5M-1,163%

Net income-$63.3M-870%

EPS (diluted)-$2.16-839%

Balance sheet

Cash & equivalents$94.9M-5.7%

Total debt$96.7M+82.5%

Total equity$254.1M-1.3%

Total assets$506.3M+13.4%

Cash flow

Operating cash flow-$32.4M-418%

CapEx$6.5M+5.3%

Free cash flow-$38.9M-1,059%

Valuation

Market cap$1.72B-24.3%

Enterprise value$1.73B-22.8%

P/S3.9×-3.0×

Profitability

Gross margin69.6%+4.3pp

Operating margin-14.9%—

Net margin-17.6%—

FCF margin3.8%+2.1pp

Returns & leverage

Return on equity-30.4%—

Debt / equity0.4×+0.2×

Current ratio3.1×-0.2×

Where this comes from

Reported directly by GeneDx Holdings in its filing.

Tagged under the XBRL concept us-gaap:LiabilitiesFairValueDisclosure.

The official record: GeneDx Holdings’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about GeneDx Holdings's total liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is GeneDx Holdings's total liabilities?: GeneDx Holdings (WGS) reported total liabilities of $220K in Q1 2026.
How has GeneDx Holdings's total liabilities changed year-over-year?: GeneDx Holdings's total liabilities decreased by 99.9% year-over-year, from $189.03M to $220K.
What is the long-term trend for GeneDx Holdings's total liabilities?: Over 5 years (2020 to 2025), GeneDx Holdings's total liabilities has grown at a -59.6% compound annual growth rate (CAGR), from $247.25M to $2.67M.
What does total liabilities mean?: The sum of all current and non-current obligations — everything the company owes to creditors, employees, governments, and other stakeholders.